1887

Abstract

Serotype 1 is a leading cause of invasive pneumococcal disease (IPD) worldwide, with the highest burden in developing countries. We report the whole-genome sequencing analysis of 448 serotype 1 isolates from 27 countries worldwide (including 11 in Africa). The global serotype 1 population shows a strong phylogeographic structure at the continental level, and within Africa there is further region-specific structure. Our results demonstrate that region-specific diversification within Africa has been driven by limited cross-region transfer events, genetic recombination and antimicrobial selective pressure. Clonal replacement of the dominant serotype 1 clones circulating within regions is uncommon; however, here we report on the accessory gene content that has contributed to a rare clonal replacement event of ST3081 with ST618 as the dominant cause of IPD in the Gambia.

Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.000027
2015-08-03
2020-03-31
Loading full text...

Full text loading...

/deliver/fulltext/mgen/1/2/mgen000027.html?itemId=/content/journal/mgen/10.1099/mgen.0.000027&mimeType=html&fmt=ahah

References

  1. Antonio M., Hakeem I., Awine T., Secka O., Sankareh K., Nsekpong D., Lahai G., Akisanya A., Egere U., other authors. 2008; Seasonality and outbreak of a predominant Streptococcus pneumoniae serotype 1 clone from The Gambia: expansion of ST217 hypervirulent clonal complex in West Africa. BMC Microbiol8:198 [CrossRef][PubMed]
    [Google Scholar]
  2. Bentley S.D., Aanensen D.M., Mavroidi A., Saunders D., Rabbinowitsch E., Collins M., Donohoe K., Harris D., Murphy L., other authors. 2006; Genetic analysis of the capsular biosynthetic locus from all 90 pneumococcal serotypes. PLoS Genet2:e31 [CrossRef][PubMed]
    [Google Scholar]
  3. Blumental S., Moïsi J.C., Roalfe L., Zancolli M., Johnson M., Burbidge P., Borrow R., Yaro S., Mueller J.E., other authors. 2015; Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodies. Clin Vaccine Immunol22:404–412 [CrossRef]
    [Google Scholar]
  4. Boetzer M., Henkel C.V., Jansen H.J., Butler D., Pirovano W.. 2011; Scaffolding pre-assembled contigs using sspace. Bioinformatics27:578–579 [CrossRef][PubMed]
    [Google Scholar]
  5. Brueggemann A.B., Spratt B.G.. 2003; Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. J Clin Microbiol41:4966–4970 [CrossRef][PubMed]
    [Google Scholar]
  6. Brueggemann A.B., Griffiths D.T., Meats E., Peto T., Crook D.W., Spratt B.G.. 2003; Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis187:1424–1432 [CrossRef][PubMed]
    [Google Scholar]
  7. Chalker A.F., Lupas A., Ingraham K., So C.Y., Lunsford R.D., Li T., Bryant A., Holmes D.J., Marra A., other authors. 2000; Genetic characterization of gram-positive homologs of the XerCD site-specific recombinases. J Mol Microbiol Biotechnol2:225–233[PubMed]
    [Google Scholar]
  8. Chan P.F., O'Dwyer K.M., Palmer L.M., Ambrad J.D., Ingraham K.A., So C., Lonetto M.A., Biswas S., Rosenberg M., other authors. 2003; Characterization of a novel fucose-regulated promoter (PfcsK) suitable for gene essentiality and antibacterial mode-of-action studies in Streptococcus pneumoniae . J Bacteriol185:2051–2058 [CrossRef][PubMed]
    [Google Scholar]
  9. Chewapreecha C., Harris S.R., Croucher N.J., Turner C., Marttinen P., Cheng L., Pessia A., Aanensen D.M., Mather A.E., other authors. 2014; Dense genomic sampling identifies highways of pneumococcal recombination. Nat Genet46:305–309 [CrossRef][PubMed]
    [Google Scholar]
  10. Cornick J.E., Bentley S.D.. 2012; Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides. Microbes Infect14:573–583 [CrossRef][PubMed]
    [Google Scholar]
  11. Cornick J.E., Harris S.R., Parry C.M., Moore M.J., Jassi C., Kamng'ona A., Kulohoma B., Heyderman R.S., Bentley S.D., Everett D.B.. 2014; Genomic identification of a novel co-trimoxazole resistance genotype and its prevalence amongst Streptococcus pneumoniae in Malawi. J Antimicrob Chemother69:368–374[PubMed][CrossRef]
    [Google Scholar]
  12. Croucher N.J., Harris S.R., Fraser C., Quail M.A., Burton J., van der Linden M., McGee L., von Gottberg A., Song J.H., other authors. 2011; Rapid pneumococcal evolution in response to clinical interventions. Science331:430–434 [CrossRef][PubMed]
    [Google Scholar]
  13. Croucher N.J., Finkelstein J.A., Pelton S.I., Mitchell P.K., Lee G.M., Parkhill J., Bentley S.D., Hanage W.P., Lipsitch M.. 2013; Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet45:656–663 [CrossRef][PubMed]
    [Google Scholar]
  14. Croucher N.J., Page A.J., Connor T.R., Delaney A.J., Keane J.A., Bentley S.D., Parkhill J., Harris S.R.. 2015; Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res Nucleic Acids Res43:e15[PubMed][CrossRef]
    [Google Scholar]
  15. Cutts F.T., Zaman S.M.A., Enwere G., Jaffar S., Levine O.S., Okoko J.B., Oluwalana C., Vaughan A., Obaro S.K., other authors. 2005; Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet365:1139–1146 [CrossRef][PubMed]
    [Google Scholar]
  16. Dagan R., Gradstein S., Belmaker I., Porat N., Siton Y., Weber G., Janco J., Yagupsky P.. 2000; An outbreak of Streptococcus pneumoniae serotype 1 in a closed community in southern Israel. Clin Infect Dis30:319–321 [CrossRef][PubMed]
    [Google Scholar]
  17. Delcher A.L., Harmon D., Kasif S., White O., Salzberg S.L.. 1999; Improved microbial gene identification with glimmer. Nucleic Acids Res27:4636–4641 [CrossRef][PubMed]
    [Google Scholar]
  18. Drummond A.J., Suchard M.A., Xie D., Rambaut A.. 2012; Bayesian phylogenetics with BEAUti and the beast 1.7. Mol Biol Evol29:1969–1973 [CrossRef][PubMed]
    [Google Scholar]
  19. Embry A., Hinojosa E., Orihuela C.J.. 2007; Regions of Diversity 8, 9 and 13 contribute to Streptococcus pneumoniae virulence. BMC Microbiol7:80 [CrossRef][PubMed]
    [Google Scholar]
  20. Everett D.B., Mukaka M., Denis B., Gordon S.B., Carrol E.D., van Oosterhout J.J., Molyneux E.M., Molyneux M., French N., Heyderman R.S.. 2011; Ten years of surveillance for invasive Streptococcus pneumoniae during the era of antiretroviral scale-up and cotrimoxazole prophylaxis in Malawi. PLoS One6:e17765 [CrossRef][PubMed]
    [Google Scholar]
  21. Harboe Z.B., Benfield T.L., Valentiner-Branth P., Hjuler T., Lambertsen L., Kaltoft M., Krogfelt K., Slotved H.C., Christensen J.J., Konradsen H.B.. 2010; Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis50:329–337 [CrossRef][PubMed]
    [Google Scholar]
  22. Harris S.R., Feil E.J., Holden M.T., Quail M.A., Nickerson E.K., Chantratita N., Gardete S., Tavares A., Day N., other authors. 2010; Evolution of MRSA during hospital transmission and intercontinental spread. Science327:469–474 [CrossRef][PubMed]
    [Google Scholar]
  23. Hausdorff W.P., Feikin D.R., Klugman K.P.. 2005; Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis5:83–93 [CrossRef][PubMed]
    [Google Scholar]
  24. Higgins M.A., Abbott D.W., Boulanger M.J., Boraston A.B.. 2009; Blood group antigen recognition by a solute-binding protein from a serotype 3 strain of Streptococcus pneumoniae . J Mol Biol388:299–309 [CrossRef][PubMed]
    [Google Scholar]
  25. Inouye M., Conway T.C., Zobel J., Holt K.E.. 2012; Short read sequence typing (SRST): multi-locus sequence types from short reads. BMC Genomics13:338 [CrossRef][PubMed]
    [Google Scholar]
  26. Iyer J.K., Milhous W.K., Cortese J.F., Kublin J.G., Plowe C.V.. 2001; Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet358:1066–1067 [CrossRef][PubMed]
    [Google Scholar]
  27. Johnson H.L., Deloria-Knoll M., Levine O.S., Stoszek S.K., Freimanis Hance L., Reithinger R., Muenz L.R., O'Brien K.L.. 2010; Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med7:e1000348 [CrossRef][PubMed]
    [Google Scholar]
  28. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., Pierce N., Vaccine Trialists Group. 2003; A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med349:1341–1348 [CrossRef][PubMed]
    [Google Scholar]
  29. Klugman K., Cutts F., Adegbola R.A., Black S., Madhi S.A., O'Brien K., Santosham M., Shinefield H.. 2008; Meta-analysis of the efficacy of conjugate vaccines against invasive pneumococcal disease. In Pneumococcal Vaccines317–326Edited by Siber G., Klugman K., Mäkelä P.. Washington, DC: American Society for Microbiology; [CrossRef]
    [Google Scholar]
  30. Köser C.U., Holden M.T., Ellington M.J., Cartwright E.J., Brown N.M., Ogilvy-Stuart A.L., Hsu L.Y., Chewapreecha C., Croucher N.J., other authors. 2012; Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med366:2267–2275 [CrossRef][PubMed]
    [Google Scholar]
  31. Le Bourgeois P., Bugarel M., Campo N., Daveran-Mingot M.L., Labonté J., Lanfranchi D., Lautier T., Pagès C., Ritzenthaler P.. 2007; The unconventional Xer recombination machinery of streptococci/lactococci. PLoS Genet3:e117[PubMed][CrossRef]
    [Google Scholar]
  32. Letunic I., Bork P.. 2011; Interactive Tree Of Life v2: online annotation and display of phylogenetic trees made easy. Nucleic Acids Res39:W475–W478 [CrossRef][PubMed]
    [Google Scholar]
  33. Li H., Durbin R.. 2009; Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics25:1754–1760 [CrossRef][PubMed]
    [Google Scholar]
  34. Li L., Stoeckert C.J. Jr, Roos D.S.. 2003; OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res13:2178–2189 [CrossRef][PubMed]
    [Google Scholar]
  35. Li M.-F., Zhang B.-C., Li J., Sun L.. 2014; Sil: a Streptococcus iniae bacteriocin with dual role as an antimicrobial and an immunomodulator that inhibits innate immune response and promotes S. iniae infection. PLoS One9:e96222 [CrossRef][PubMed]
    [Google Scholar]
  36. Mukouhara T., Arimoto T., Cho K., Yamamoto M., Igarashi T.. 2011; Surface lipoprotein PpiA of Streptococcus mutans suppresses scavenger receptor MARCO-dependent phagocytosis by macrophages. Infect Immun79:4933–4940 [CrossRef][PubMed]
    [Google Scholar]
  37. O'Brien K.L., Wolfson L.J., Watt J.P., Henkle E., Deloria-Knoll M., McCall N., Lee E., Mulholland K., Levine O.S., Cherian T., Hib and Pneumococcal Global Burden of Disease Study Team. 2009; Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet374:893–902 [CrossRef][PubMed]
    [Google Scholar]
  38. Pai R., Moore M.R., Pilishvili T., Gertz R.E., Whitney C.G., Beall B., Active Bacterial Core Surveillance Team. 2005; Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J Infect Dis192:1988–1995 [CrossRef][PubMed]
    [Google Scholar]
  39. United Nations High Commissioner for Refugees 2000; The State of the World's Refugees, 2000: Fifty Years of Humanitarian Action Oxford: Oxford University Press;
    [Google Scholar]
  40. Ritchie N.D., Mitchell T.J., Evans T.J.. 2012; What is different about serotype 1 pneumococci?. Future Microbiol7:33–46 [CrossRef][PubMed]
    [Google Scholar]
  41. Seemann T.. 2014; Prokka: rapid prokaryotic genome annotation. Bioinformatics30:2068–2069 [CrossRef][PubMed]
    [Google Scholar]
  42. Stamatakis A.. 2006; RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics22:2688–2690 [CrossRef][PubMed]
    [Google Scholar]
  43. Turner P., Turner C., Jankhot A., Helen N., Lee S.J., Day N.P., White N.J., Nosten F., Goldblatt D.. 2012; A longitudinal study of Streptococcus pneumoniae carriage in a cohort of infants and their mothers on the Thailand-Myanmar border. PLoS One7:e38271 [CrossRef][PubMed]
    [Google Scholar]
  44. Williams T.M., Loman N.J., Ebruke C., Musher D.M., Adegbola R.A., Pallen M.J., Weinstock G.M., Antonio M.. 2012; Genome analysis of a highly virulent serotype 1 strain of Streptococcus pneumoniae from West Africa. PLoS One7:e26742 [CrossRef][PubMed]
    [Google Scholar]
  45. Yildirim I., Hanage W.P., Lipsitch M., Shea K.M., Stevenson A., Finkelstein J., Huang S.S., Lee G.M., Kleinman K., Pelton S.I.. 2010; Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine29:283–288 [CrossRef][PubMed]
    [Google Scholar]
  46. Zerbino D.R., Birney E.. 2008; Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res18:821–829 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/mgen/10.1099/mgen.0.000027
Loading
/content/journal/mgen/10.1099/mgen.0.000027
Loading

Data & Media loading...

Supplements

Supplementary Data

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error